These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31382146)

  • 21. Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in western region of Turkey.
    Tamer GS; Dundar D; Caliskan E
    Clin Invest Med; 2009 Feb; 32(1):E43-7. PubMed ID: 19178878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of preconception TORCH infections and its influential factors: evidence from over 2 million women with fertility desire in southern China.
    Han L; Li R; Xiong W; Hu Y; Wu J; Liu X; Nie H; Qin W; Ling L; Li M
    BMC Womens Health; 2023 Aug; 23(1):425. PubMed ID: 37563634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom.
    Abdel-Fattah SA; Bhat A; Illanes S; Bartha JL; Carrington D
    Prenat Diagn; 2005 Nov; 25(11):1028-31. PubMed ID: 16231309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardization of an in-house multiplex real-time polymerase chain reaction for the simultaneous detection of
    Rajendiran P; Saravanan N; Ramamurthy M; Sankar S; Aruliah R; Nandagopal B; Sridharan G
    Indian J Public Health; 2021; 65(4):369-374. PubMed ID: 34975080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroepidemiology of TORCH Infections among 1.7 Million Women of Childbearing Age in Rural China: A Population-Based Cross-Sectional Study.
    Qin X; Zhang S; Liu H; Cheng G; Liu Y; Hu M; Liu N; Zhang M
    Am J Trop Med Hyg; 2021 Sep; 105(5):1202-1209. PubMed ID: 34544045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TORCH serologies and specific IgM antibody determination in acquired and congenital infections.
    Fung JC; Tilton RC
    Ann Clin Lab Sci; 1985; 15(3):204-11. PubMed ID: 2986514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Utility of Maternal TORCH Screening Due to Obstetrical Indications in Detecting Congenital Infections: A Retrospective Observational Study.
    Abu Shqara R; Or S; Abu Zraki A; Rizik J; Glikman D; Rechnitzer H; Lowenstein L; Frank Wolf M
    Pediatr Infect Dis J; 2024 Jan; 43(1):69-73. PubMed ID: 37725823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Investigation on TORCH infections for pregnant women and neonates in Yan'an City].
    Zhang QQ; Cheng JZ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Aug; 24(4):386, 392. PubMed ID: 23236780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection in pregnancy and cerebral palsy.
    Schendel DE
    J Am Med Womens Assoc (1972); 2001; 56(3):105-8. PubMed ID: 11506145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exhaustive TORCH Pathogen Diagnostics Corroborate Zika Virus Etiology of Congenital Malformations in Northeastern Brazil.
    Moreira-Soto A; Cabral R; Pedroso C; Eschbach-Bludau M; Rockstroh A; Vargas LA; Postigo-Hidalgo I; Luz E; Sampaio GS; Drosten C; Netto EM; Jaenisch T; Ulbert S; Sarno M; Brites C; Drexler JF
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30089647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Line Immunoassay: A Rapid Test for Screening TORCH Complex in Antenatal Patients with Bad Obstetric History.
    Kumar H; Singh VA; Isha M; Mehta S; Garg R; Shinu P
    Mymensingh Med J; 2018 Jul; 27(3):641-644. PubMed ID: 30141457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TORCH Infections. Toxoplasmosis, Other (syphilis, varicella-zoster, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes infections.
    Stegmann BJ; Carey JC
    Curr Womens Health Rep; 2002 Aug; 2(4):253-8. PubMed ID: 12150751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible role of TORCH agents in congenital malformations in Gorgan, northern Islamic Republic of Iran.
    Golalipour MJ; Khodabakhshi B; Ghaemi E
    East Mediterr Health J; 2009; 15(2):330-6. PubMed ID: 19554979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TORCH testing in HIV-infected women.
    Helfgott A
    Clin Obstet Gynecol; 1999 Mar; 42(1):149-62; quiz 174-5. PubMed ID: 10073308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukocyte transforming agent (Epstein-Barr virus) in newborn infants and older individuals.
    Visintine AM; Gerber P; Nahmias AJ
    J Pediatr; 1976 Oct; 89(4):571-5. PubMed ID: 182946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Yield and costs of screening growth-retarded infants for torch infections.
    Khan NA; Kazzi SN
    Am J Perinatol; 2000; 17(3):131-5. PubMed ID: 11012137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seasonal influence on TORCH infection and analysis of multi-positive samples with indirect immunofluorescence assay.
    Chen L; Liu J; Shi L; Song Y; Song Y; Gao Y; Dong Y; Li L; Shen M; Zhai Y; Cao Z
    J Clin Lab Anal; 2019 May; 33(4):e22828. PubMed ID: 30666721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence and Influence of Torch Infections in High Risk Pregnant Women: A Large Study from South India.
    Prasoona KR; Srinadh B; Sunitha T; Sujatha M; Deepika ML; Vijaya Lakshmi B; Ramaiah A; Jyothy A
    J Obstet Gynaecol India; 2015 Oct; 65(5):301-9. PubMed ID: 26405399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of toxoplasma gondii, rubella virus, cytomegalovirus herpes simplex virus (TORCH) and syphilis in Jamaican pregnant women.
    Prabhakar P; Bailey A; Smikle MF; McCaw-Binns A; Ashley D
    West Indian Med J; 1991 Dec; 40(4):166-9. PubMed ID: 1664562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic review of maternal TORCH serology as a screen for suspected fetal infection.
    Fitzpatrick D; Holmes NE; Hui L
    Prenat Diagn; 2022 Jan; 42(1):87-96. PubMed ID: 34893980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.